-
4m 16sPart 3 | Session 1 4 Trials That Will Change My Practice with Dr Luigi Di Biase
-
5m 18sPart 3 | Session 2 AF & EP in 2026: Five Things That Will Change Daily Practice
-
10m 44sPart 1 | Session 1 Complication Prevention in Complex AF and VT Procedures
-
12m 35sPart 1 | Session 2 Will PFA Redefine AF Ablation Strategies in 2026?
-
9m 39sPart 1 | Session 3 Redo AF Ablation: When to Go Beyond PVI?
-
4m 10sPart 2 | Session 1 Stroke Management After AF Ablation
-
7m 20sPart 2 | Session 2 VOLT AF IDE
-
5m 53sPart 2 | Session 3 VERITAS Study: Next-Generation LAA Closure with Amulet 360
-
3m 48sPart 2 | Session 4 STYLE AF Update: Venous Vascular Closure in AF Patients
-
4m 50sPart 2 | Session 5 Balloon-in-Basket PFA without Propofol
AF Symposium 2026 - Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, New York, NY, US) joins us to discuss findings from the ADVENT LTO study, evaluating long-term outcomes and atrial fibrillation progression in patients who received ablation with the FARAPULSE Pulsed Field Ablation System compared to thermal ablation.
The study tracked AF progression patterns, arrhythmia recurrence rates, and long-term freedom from atrial arrhythmias in paroxysmal AF patients, comparing outcomes between PFA and conventional thermal ablation approaches over extended follow-up.
Interview Questions:
- Tell us about the ADVENT LTO results – is 'fast' PFA just creating temporary stunning instead of permanent transmural lesions?
- How does this translate to patient outcomes?
- Is this data enough for us to change practice – what are your recommendations?
- If this was your heart, would you be happy with a quick ablation time?
Recorded on-site at AF Symposium 2026, Boston.
Editor: Jordan Rance
Videographer: David Ben-Harosh
Support: This is an independent interview produced by Radcliffe Cardiology.
Stay up to date with our video collection covering late-breaking data from AF Symposium 2026 in Boston. Don't miss our short, accessible Expert Interviews, Discussions and Highlights of the most pertinent trials.
More from this programme
Part 1
Clinical Discussions
Part 2
Expert Interviews
Faculty Biographies
Vivek Reddy
Director of Cardiac Arrhythmia Services
Dr. Vivek Y. Reddy is a renowned cardiac electrophysiologist based in New York, currently serving as Director of Cardiac Arrhythmia Services for The Mount Sinai Hospital and Director of Electrophysiology for the Mount Sinai Health System. He holds the Leona M. and Harry B. Helmsley Charitable Trust Professorship of Medicine in Cardiac Electrophysiology at the Icahn School of Medicine at Mount Sinai. Dr. Reddy is recognized internationally for his groundbreaking clinical work in heart rhythm disorders, including atrial fibrillation, ventricular tachycardia, and the development of device-based stroke prevention strategies. Under his leadership, Mount Sinai has been the lead investigational site for numerous multinational clinical trials, including those exploring pulsed field ablation and other emerging arrhythmia technologies. In 2014, he implanted the world’s first miniature leadless pacemaker in the United States at The Mount Sinai Hospital, marking a major advance in pacing…
Comments